{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:14:32Z","timestamp":1789503272488,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013719","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000}}],"reference-count":210,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013719.pub2","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T06:42:34Z","timestamp":1698043354000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatments for alopecia areata: a network meta-analysis"],"prefix":"10.1002","volume":"2023","author":[{"given":"Miriam","family":"Mateos-Haro","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit; Hospital Universitario Ram\u00f3n y Cajal (IRYCIS); Madrid Spain"},{"name":"Doctoral programme in Clinical Medicine and Public Health; Universidad de Granada; Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Novoa-Candia","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department; Hospital San Jose-Fundaci\u00f3n Universitaria de Ciencias de la Salud-FUCS; Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"S\u00e1nchez Vanegas","sequence":"additional","affiliation":[{"name":"Hospital Universitario Mayor-M\u00e9deri; Universidad del Rosario; Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Correa-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit; Hospital Universitario Ram\u00f3n y Cajal (IRYCIS); Madrid Spain"},{"name":"Faculty of Medicine; Universidad Francisco de Vitoria; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gaetano Gil","sequence":"additional","affiliation":[{"name":"Clinical Biostatistics Unit; Hospital Universitario Ram\u00f3n y Cajal (IRYCIS); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"WHO Collaborating Centre for Global Women\u2019s Health, Institute of Metabolism and Systems Research; University of Birmingham; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ortega-Quijano","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Universitario Ram\u00f3n y Cajal; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra Gizeth","family":"Urue\u00f1a Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital San Jose-Fundaci\u00f3n Universitaria de Ciencias de la Salud-FUCS; Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saceda-Corralo","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Universitario Ram\u00f3n y Cajal; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayeb","family":"Bennouna-Dalero","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Public Health Department; Hospital Universitario Ram\u00f3n y Cajal, IRYCIS; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Giraldo","sequence":"additional","affiliation":[{"name":"Paediatric Dermatology Department; Hospital San Jose-Fundaci\u00f3n Universitaria de Ciencias de la Salud-FUCS; Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"c\/o Cochrane Skin Group; The University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Va\u00f1o-Galv\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Universitario Ram\u00f3n y Cajal; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Zamora","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research; University of Birmingham; Birmingham UK"},{"name":"Clinical Biostatistics Unit; Hospital Universitario Ram\u00f3n y Cajal (IRYCIS). CIBER Epidemiology and Public Health (CIBERESP); Madrid Spain"},{"name":"Cochrane Associate Centre of Madrid; Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"10.1002\/14651858.CD013719.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1080\/09546634.2020.1793893","article-title":"Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata","volume":"33","author":"Abdallah","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0002|cit2","unstructured":"Abdel Motaleb AA Sayed DS Different freezing time of superficial liquid nitrogen cryotherapy in treatment of recalcitrant alopecia areata: Randomized clinical trial Dermatologic Therapy 10.1111\/dth.13640"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0003|cit3","first-page":"2","article-title":"Efficacy and safety of diphenylcyclopropenone (DPCP) and anthralin combination vs DPCP alone in the treatment of chronic patchy alopecia areata","volume":"12","author":"Agrawal","year":"2021","journal-title":"Journal of the Dermatology Nurses' Association"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1456-62","DOI":"10.1111\/jocd.12858","article-title":"Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata","volume":"18","author":"Albalat","year":"2019","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"130-6","DOI":"10.1159\/000494613","article-title":"Janus kinase inhibitors for the treatment of severe alopecia areata: an open-label comparative study","volume":"235","author":"Almutairi","year":"2019","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0006|cit6","first-page":"63-71","article-title":"Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children","volume":"78","author":"Amaral Maia","year":"2003","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.22037\/ijpr.2020.113868.14536","article-title":"Oral pulse betamethasone, methotrexate, and combination therapy to treat severe alopecia areata: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Asilian","year":"2020","journal-title":"Iranian Journal of Pharmaceutical Research"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0008|cit8","unstructured":"Comparison of betamethasone and methotrexate efficacy in the treatment of alopecia areata who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20181226042136N1"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0009|cit9","first-page":"43","article-title":"Efficiacy of diphenylcyclopropenone and anthralin in patients with alopecia areata: a compration study","volume":"40","author":"Azimi Alamdari","year":"2018","journal-title":"Medical Journal of Tabriz University of Medical Sciences and Health Services"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0010|cit10","unstructured":"Diphencyprone and anthralin in alopecia areata trialsearch.who.int\/?TrialID=IRCT201410113566N5"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.abd.2020.06.018","article-title":"Randomized controlled study comparing the use of diphencyprone and anthralin in the treatment of extensive chronic alopecia areata","volume":"96","author":"Barreto-Rocha","year":"2021","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"12","key":"10.1002\/14651858.CD013719.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ijd.14192","article-title":"Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study","volume":"57","author":"Bokhari","year":"2018","journal-title":"International Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD013719.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archderm.136.10.1276","article-title":"Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream","volume":"136","author":"Charuwichitratana","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2015.04.049","article-title":"Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study","volume":"73","author":"Chu","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD013719.pub2-BIB0015|cit15","first-page":"860","article-title":"Intralesional triamcinolone acetonide versus topical betamethasone valerate in the management of localized alopecia areata","volume":"25","author":"Devi","year":"2015","journal-title":"Journal of the College of Physicians and Surgeons-Pakistan"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.12437","article-title":"Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation","volume":"30","author":"El Taieb","year":"2017","journal-title":"Dermatologic Therapy"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0017|cit17","first-page":"431","article-title":"3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata","volume":"41","author":"Fransway","year":"1988","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"107971","DOI":"10.1016\/j.intimp.2021.107971","article-title":"A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata","volume":"99","author":"Ghandi","year":"2021","journal-title":"International Immunopharmacology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0019|cit19","unstructured":"Diphencyprone and anthralin in alopecia areata who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20141209020250N4"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0020|cit20","first-page":"72-5","article-title":"Steroids in alopecia areata: oral minipulse vs daily dose","volume":"45","author":"Goyal","year":"2000","journal-title":"Indian Journal of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0021|cit21","unstructured":"A study to evaluate the effects of platelet-rich plasma on hair regrowth in alopecia areata www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2017\/02\/007932"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/ijd.IJD_481_16","article-title":"Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata","volume":"64","author":"Gupta","year":"2019","journal-title":"Indian Journal of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0023|cit23","unstructured":"Guttman-Yassky E Renert-Yuval Y Bares J Chima M Hawkes JE Gilleaudeau P Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients Allergy 10.1111\/all.15071"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0024|cit24","unstructured":"Hamdino M El-Barbary RA Darwish HM Intralesional methotrexate versus triamcinolone acetonide for localized alopecia areata treatment: a randomized clinical trial Journal of Cosmetic Dermatology 10.1111\/jocd.14090"},{"issue":"11","key":"10.1002\/14651858.CD013719.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/archderm.134.11.1349","article-title":"Randomized trial of aromatherapy. Successful treatment for alopecia areata","volume":"134","author":"Hay","year":"1998","journal-title":"Archives of Dermatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013719.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/S0926-9959(98)95096-6","article-title":"The use of aromatherapy as a successful treatment for alopecia areata","volume":"11","author":"Hay","year":"1998","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"e14388","DOI":"10.1111\/dth.14388","article-title":"A randomized, placebo and active controlled, split scalp study to evaluate the efficacy of platelet-rich plasma in patchy alopecia areata of the scalp","volume":"33","author":"Hegde","year":"2020","journal-title":"Dermatologic Therapy"},{"issue":"269","key":"10.1002\/14651858.CD013719.pub2-BIB0028|cit28","first-page":"2315","article-title":"Comparing the efficiency of combination of minoxidil solution and tacrolimus cream with minoxidil solution alone in the treatment of alopecia areata","volume":"31","author":"Iraji","year":"2014","journal-title":"Journal of Isfahan Medical School"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/JCAS.JCAS_16_19","article-title":"Comparative evaluation of therapeutic efficacy of intralesional injection of triamcinolone acetonide versus intralesional autologous platelet-rich plasma injection in alopecia areata","volume":"13","author":"Kapoor","year":"2020","journal-title":"Journal of Cutaneous and Aesthetic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0031|cit31","first-page":"575","article-title":"Topical minoxidil in alopecia areata: immunopathologic studies","volume":"90","author":"Khoury","year":"1988","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12611409","article-title":"Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration","volume":"99","author":"Khoury","year":"1992","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0033|cit33","unstructured":"Comparison of the Effectiveness of 308-nm Xenon Chloride Excimer Laser on the Treatment of Patchy Alopecia Areata who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20150923024147N1"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/lsm.23501","article-title":"Comparison of the efficacy and safety of 308-nm excimer laser with intralesional corticosteroids for the treatment of alopecia areata: A randomized controlled study","volume":"54","author":"Kianfar","year":"2021","journal-title":"Lasers in Surgery and Medicine"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0035|cit35","unstructured":"A multicenter, randomized, double-blind, placebo-controlled, operationally seamless, adaptive phase 2\/3 study to evaluate the efficacy and safety of baricitinib in adult patients with severe or very severe alopecia areata (BRAVE-AA1) (I4V-MC-JAHO). rctportal.niph.go.jp\/s\/detail\/jp?trial_id=JapicCTI-184174"},{"issue":"9","key":"10.1002\/14651858.CD013719.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"PB18","DOI":"10.1016\/j.jid.2021.07.049","article-title":"Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)","volume":"141","author":"King","year":"2021","journal-title":"Journal of Investigative Dermatology"},{"issue":"18","key":"10.1002\/14651858.CD013719.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 Trials of Baricitinib for Alopecia Areata","volume":"386","author":"King","year":"2022","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two Phase 3 Trials of Baricitinib for Alopecia Areata","volume":"386(18)","author":"King","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-7753.82123","article-title":"Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata","volume":"3","author":"Kuldeep","year":"2011","journal-title":"International Journal of Trichology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0040|cit40","unstructured":"Cyclosporin for moderate to severe alopecia areata and tofacitinib extension who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12618001084279"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0041|cit41","first-page":"56","article-title":"Cyclosporin for moderate to severe alopecia areata: a double-blind, randomised, placebo-controlled clinical trial of efficacy and safety","volume":"60","author":"Lai","year":"2019","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0042|cit42","first-page":"56","article-title":"Health-related quality of life of patients with alopecia areata","volume":"60","author":"Lai","year":"2019","journal-title":"Australasian Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"694-701","DOI":"10.1016\/j.jaad.2019.04.053","article-title":"Cyclosporine for moderate-to-severe alopecia areata: a double-blind, randomized, placebo-controlled clinical trial of efficacy and safety","volume":"81","author":"Lai","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"50","key":"10.1002\/14651858.CD013719.pub2-BIB0044|cit44","first-page":"250","article-title":"Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata","volume":"32","author":"Lai","year":"2019","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamadermatol.2013.5764","article-title":"Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial","volume":"150","author":"Lenane","year":"2014","journal-title":"JAMA Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0046|cit46","unstructured":"A trial of clobetasol propionate versus hydrocortisone in children with alopecia areata clinicaltrials.gov\/ct2\/show\/NCT01453686"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0047|cit47","first-page":"475","article-title":"Therapeutic effects of topical minoxidil or rosemary and the combination of both on the treatment of alopecia areata","volume":"4","author":"Lohrasb","year":"2015","journal-title":"Journal of Fasa University of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0048|cit48","first-page":"22","article-title":"Topical application of minoxidil in treating alopecia areata---a randomized double-blind control study in 162 cases","volume":"20","author":"Luo","year":"1991","journal-title":"Journal of Clinical Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD013719.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00403-018-1876-y","article-title":"A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata","volume":"311","author":"Mikhaylov","year":"2019","journal-title":"Archives of Dermatological Research"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0051|cit51","unstructured":"Pilot study of the safety and efficacy of apremilast in subjects with moderate to severe alopecia areata clinicaltrials.gov\/show\/NCT02684123"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0052|cit52","first-page":"348-50","article-title":"Comparative efficacy of topical anthralin and intralesional triamcionolone in the treatment of alopecia areata","volume":"62","author":"Narahari","year":"1996","journal-title":"Indian Journal of Dermatology, Venerology and Leprology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e15358","DOI":"10.1111\/dth.15358","article-title":"Comparative study of the use of fractional CO2 laser versusthe use of liquid nitrogen cryotherapy in the treatment ofalopecia areata in a sample of the Egyptian population","volume":"35","author":"Nouh","year":"2022","journal-title":"Dermatologic Therapy"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2019.10.016","article-title":"Ruxolitinib cream for the treatment of patients with alopecia areata: a 2-part, double-blind, randomized, vehicle-controlled phase 2 study","volume":"82","author":"Olsen","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5455\/gulhane.38258","article-title":"Efficacy of aromatherapy in the treatment of localized alopecia areata: A double-blind placebo controlled study","volume":"57","author":"Ozmen","year":"2015","journal-title":"Gulhane T\u0131p Derg"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD013719.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD013719.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0190-9622(87)70096-6","article-title":"Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy","volume":"16","author":"Price","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e14555","DOI":"10.1111\/dth.14555","article-title":"Identification of novel step-up regimen of intralesional triamcinolone acetonide in scalp alopecia areata based on a double-blind randomized controlled trial","volume":"34","author":"Rajan","year":"2021","journal-title":"Dermatologic Therapy"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0059|cit59","first-page":"1","article-title":"Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial","volume":"00","author":"Rashad","year":"2022","journal-title":"Journal of Cosmetic Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0060|cit60","first-page":"284-91","article-title":"Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant alopecia areata","volume":"33","author":"Saif","year":"2012","journal-title":"Saudi Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/JEWD.JEWD_7_20","article-title":"Superficial cryotherapy versus topical psoralen and ultraviolet A in the treatment of alopecia areata: a randomized, controlled trial","volume":"17","author":"Sayed","year":"2020","journal-title":"Journal of the Egyptian Women's Dermatologic Society"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013719.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0190-9622(93)70238-O","article-title":"Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation","volume":"29","author":"Shapiro","year":"1993","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0063|cit63","unstructured":"Effectiveness of betamethasone versus triamcinolone injection in the treatment of alopecia trialsearch.who.int\/?TrialID=RBR-5kyg2r"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0064|cit64","unstructured":"Sousa V Arcanjo FP Aguiar F Vasconcelos J Oliveira AF Honorio A Intralesional betamethasone versus triamcinolone acetonide in the treatment of localized alopecia areata: a within-patient randomized controlled trial Journal of Dermatological Treatment 10.1080\/09546634.2020.1788703"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0065|cit65","unstructured":"Alefacept in patients with severe scalp alopecia areata clinicaltrials.gov\/ct2\/show\/NCT00167102"},{"issue":"11","key":"10.1002\/14651858.CD013719.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/archdermatol.2009.264","article-title":"Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study","volume":"145","author":"Strober","year":"2009","journal-title":"Archives of Dermatology"},{"issue":"b","key":"10.1002\/14651858.CD013719.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3889\/oamjms.2022.7428","article-title":"Low Level Laser versus Platelet-rich Plasma in Treatment of Alopecia Areata: A Randomized Controlled Intra-patient Comparative Study","volume":"10","author":"Tawfik","year":"2022","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/1947-2714.185029","article-title":"Comparative study of efficacy and safety of topical squaric acid dibutylester and diphenylcyclopropenone for the treatment of alopecia areata","volume":"8","author":"Tiwary","year":"2016","journal-title":"North American Journal of Medical Sciences"},{"issue":"9","key":"10.1002\/14651858.CD013719.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e15696","DOI":"10.1111\/dth.15696","article-title":"Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata","volume":"35","author":"Toma","year":"2022","journal-title":"Dermatologic Therapy"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD013719.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0190-9622(86)70158-8","article-title":"Therapies versus placebo in the treatment of patchy alopecia areata","volume":"15","author":"Tosti","year":"1986","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD013719.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1468-3083.2006.01781.x","article-title":"Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial","volume":"20","author":"Tosti","year":"2006","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.12397","article-title":"A randomized, double-blind, placebo and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata","volume":"169","author":"Trink","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/09546634.2011.590788","article-title":"The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata","volume":"23","author":"Ucak","year":"2012","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jdv.12043","article-title":"Prognostic factors that affect the response to topical treatment in patchy alopecia areata","volume":"28","author":"Ucak","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.53350\/pjmhs22166133","article-title":"Efficacy of Topical Clobetasol Propionate 0.05% Ointment and TopicalTacrolimus 0.1% Ointment in Treatment of Alopecia Areata: RCT","volume":"16","author":"Ullah","year":"2022","journal-title":"Pakistan Journal of Medical & Health Sciences"},{"issue":"8","key":"10.1002\/14651858.CD013719.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"753-61","DOI":"10.1080\/09546634.2017.1329497","article-title":"Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults","volume":"28","author":"Ustuner","year":"2017","journal-title":"Journal of Dermatological Treatment"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD013719.pub2-BIB0077|cit77","first-page":"AB112","article-title":"Comparison of effectiveness of weekly azathioprine pulse (WAP) and betamethasone oral mini pulse (BOMP) in the treatment of moderate to severe alopecia areata","volume":"72","author":"Verma","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archderm.1985.01660050039009","article-title":"Topical minoxidil lacks efficacy in alopecia areata","volume":"121","author":"White","year":"1985","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000371416","article-title":"Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: a pilot study","volume":"230","author":"Zaher","year":"2014","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0080|cit80","first-page":"795-98","article-title":"Efficacy of topical 5% minoxodil solution in the treatment of alopecia areata","volume":"11","author":"Rashid","year":"2017","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","article-title":"Alopecia areata: topical immunotherapy treatment with diphencyprone","volume":"22","author":"Avgerinou","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1600-0625.2010.01097.x","article-title":"Comparison of the efficacy and safety of 5% garlic gel and clobetasol propionate ointment in the treatment of alopecia areata: an investigator-blinded randomized controlled trial: emerging technologies and therapies","volume":"19","author":"Bautista","year":"2010","journal-title":"Experimental Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/S0190-9622(03)00800-4","article-title":"Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study","volume":"49","author":"Bernardo","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"184-9","DOI":"10.1111\/ijd.13533","article-title":"Efficacy of superficial cryotherapy on the eyebrows of patients with alopecia universalis also treated with contact immunotherapy on the scalp: a prospective, split-face comparative study","volume":"56","author":"Choe","year":"2017","journal-title":"International Journal of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD013719.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-4362.2001.01261-3.x","article-title":"Paroxetine in alopecia areata","volume":"40","author":"Cipriani","year":"2001","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2001.109309","article-title":"The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata","volume":"44","author":"Cotellessa","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013719.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/0926-9959(95)96512-7","article-title":"PUVA treatment for alopecia areata","volume":"5","author":"Denli","year":"1995","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1445\u201369","DOI":"10.1111\/j.1468-3083.2009.03243.x","article-title":"Capsaicin vs clobetasol for the treatment of localized alopecia areata","volume":"23","author":"Ehsani","year":"2009","journal-title":"Journal European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"55-64","DOI":"10.1080\/09546634.2017.1330527","article-title":"Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata","volume":"29","author":"El-Ashmawy","year":"2018","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/09546634.2018.1543847","article-title":"A clinical and immunological study of phototoxic regimen of ultraviolet A for treatment of alopecia areata: a randomized controlled clinical trial","volume":"30","author":"El-Mofty","year":"2018","journal-title":"Journal of Dermatological Treatment"},{"issue":"8","key":"10.1002\/14651858.CD013719.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"629-36","DOI":"10.1007\/s00403-019-01943-8","article-title":"Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial","volume":"311","author":"El Taieb","year":"2019","journal-title":"Archives of Dermatological Research"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1265-7","DOI":"10.1016\/j.jaad.2016.08.033","article-title":"Increased cutaneous stimulation is required for C-fiber sensory perception in alopecia areata: a double-blind study","volume":"75","author":"Farah","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ced.14084","article-title":"Combination of photodynamic therapy with 5-aminolaevulinic acid and microneedling in the treatment of alopecia areata resistant to conventional therapies: our experience with 41 patients","volume":"45","author":"Giorgio","year":"2020","journal-title":"Clinical & Experimental Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD013719.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"607-14","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Archives of Dermatological Research"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0095|cit95","first-page":"52-3","article-title":"Selective oral JAK3 and TYK2\/JAK1 kinase inhibitors both demonstrate significant hair-growth compared to placebo and improvement of hair-associated keratins in patients with moderate-to-severe alopecia areata","volume":"27","author":"Guttman-Yassky","year":"2018","journal-title":"Experimental Dermatology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD013719.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/J.JID.2019.03.620","article-title":"544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2\/JAK1)","volume":"139","author":"Guttman-Yassky","year":"2019","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0097|cit97","unstructured":"Comparison study of two treatment modalities i.e. calcipotriol ointment and calcipotriol ointment along with ultraviolet phototherapy in special kind of hair loss disorder called as alopecia areata www.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2015\/11\/006363"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"127-32","DOI":"10.1097\/01.EWX.0000545039.61182.8b","article-title":"Effectiveness of topical calcipotriol (0.005%) ointment with or without narrowband ultraviolet B phototherapy in patients with alopecia areata: a randomized evaluator-blinded placebo-controlled trial","volume":"15","author":"Jaiswal","year":"2018","journal-title":"Journal of the Egyptian Women's Dermatologic Society"},{"issue":"12","key":"10.1002\/14651858.CD013719.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/ijd.13676","article-title":"Comparison of the topical FK506 and clobetasol propionate as first-line therapy in the treatment of early alopecia areata","volume":"56","author":"Jung","year":"2017","journal-title":"International Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"361-65","DOI":"10.1159\/000092287","article-title":"A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.11.006","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"72","author":"Lattouf","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00403-019-02004-w","article-title":"The comparison of therapeutic effect of clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial","volume":"312","author":"Moosavi","year":"2019","journal-title":"Archives of Dermatological Research"},{"issue":"11","key":"10.1002\/14651858.CD013719.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0105|cit105","unstructured":"To compare the effectiveness of giving triamcinolone acetonide in the lesion through injection and through microneedling in patients of alopecia areata who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2018\/07\/014701"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0106|cit106","unstructured":"A study to compare topical therapy (DPCP) in alopecia areata versus oral steroids who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2018\/10\/015870"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0107|cit107","unstructured":"Comparing the efficacy, complications and satisfaction of patients with alopecia areata limited head in a multigroup study with latanopprost eye drops, minoxidil and betamethasone fa.irct.ir\/trial\/59903"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0108|cit108","unstructured":"The efficiency of the methotrexate at patients affected by grave pelade clinicaltrials.gov\/show\/NCT02037191"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0109|cit109","unstructured":"Topical 5% minoxidil and potent topical corticosteroid versus intralesional corticosteroid in the treatment of alopecia areata clinicaltrials.gov\/show\/NCT03535233"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0110|cit110","unstructured":"Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRP https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05251831"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0111|cit111","unstructured":"Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for treatment of chronic extensive alopecia areata: a spilt-scalp double-blind controlled study trialsearch.who.int\/?TrialID=TCTR20210521008"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0112|cit112","unstructured":"Comparing three different modalities in patchy hair loss who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2013\/08\/003880"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0113|cit113","unstructured":"A study to compare the efficacy of two different procedural treatments of patchy hair loss who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2018\/02\/012046"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0114|cit114","unstructured":"A study to compare effect of three common locally applied medicines in alopecia areata (a disease causing patchy hair loss) of scalp who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2019\/02\/017483"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0115|cit115","unstructured":"Microneedling with topical autologous platelet rich plasma versus intralesional triamcinolone acetonide in alopecia areata ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=53489"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0116|cit116","unstructured":"COMPARING LASER WITH STEROID INJECTION IN ALOPECIA AREATA ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=62758"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0117|cit117","unstructured":"Use of various topical ointments for the treatment of localized hair loss ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=66367"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0118|cit118","unstructured":"Triamcinolone acetonid in alopecia areata trialsearch.who.int\/?TrialID=IRCT20100314003566N10"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0119|cit119","unstructured":"The comparison of two regimens of diphencyprone in alopecia areata patients who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT20141209020250N5"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0120|cit120","unstructured":"Comparison of the effect of diphenciprone alone and diphenciprone with intralesional injection of platelet-rich plasma in alopecia areata trialsearch.who.int\/?TrialID=IRCT20200130046311N1"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0121|cit121","unstructured":"STS-01 for the treatment of alopecia areata isrctn.com\/ISRCTN14007390"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0122|cit122","unstructured":"A study on an effective protocol for cryotherapy in Alopecia areata trialsearch.who.int\/Trial2.aspx?TrialID=KCT0006802"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0123|cit123","unstructured":"Cryotherapy versus steroids in alopecia areata: trichoscopic evaluation clinicaltrials.gov\/show\/NCT03473600"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0124|cit124","unstructured":"Modified SALT score for alopecia areata clinicaltrials.gov\/show\/NCT04412148"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0125|cit125","unstructured":"Intralesional vitamin D in alopecia areata clinicaltrials.gov\/ct2\/show\/NCT04660786"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0126|cit126","unstructured":"Excimer light and topical steroid in treatment of alopecia areata clinicaltrials.gov\/ct2\/show\/NCT04793945"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0127|cit127","unstructured":"Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia Areata clinicaltrials.gov\/ct2\/show\/NCT05414266"},{"issue":"12","key":"10.1002\/14651858.CD013719.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CCID.S22767","article-title":"Alopecia areata: a new treatment plan","volume":"4","author":"Alsantali","year":"2011","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.jisp.2017.10.010","article-title":"Quantifying alopecia areata via texture analysis to automate the SALT score computation","volume":"19","author":"Bernardis","year":"2018","journal-title":"Journal of Investigative Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD013719.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2018.09.164","article-title":"Novel effect of sildenafil on hair growth","volume":"505","author":"Choi","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","article-title":"The Skindex instruments to measure the effects of skin disease on quality of life","volume":"30","author":"Chren","year":"2012","journal-title":"Dermatologic Clinics"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0135|cit135","unstructured":"More about the Cochrane Skin Specialised Register skin.cochrane.org\/search-methods"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jaad.2016.12.007","article-title":"Comorbidities in patients with alopecia areata","volume":"76","author":"Conic","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0137|cit137","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004413.pub2","article-title":"Interventions for alopecia areata","author":"Delamere","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1111\/j.1468-3083.2012.04629.x","article-title":"Quality of life in alopecia areata: a disease-specific questionnaire","volume":"27","author":"Fabbrocini","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"10","key":"10.1002\/14651858.CD013719.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2010.04576.x","article-title":"Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study","volume":"49","author":"Farshi","year":"2010","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0141|cit141","doi-asserted-by":"crossref","unstructured":"Ferreira SB Scheinberg M Steiner D Steiner T Bedin GL Ferreira RB Remarkable improvement of nail changes in alopecia areata universalis with 10 months of treatment with tofacitinib: a case report Case Reports in Dermatology 2016 8 3 262 6 28101018","DOI":"10.1159\/000450848"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD013719.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.15545","article-title":"Minoxidil for patchy alopecia areata: systematic review and meta-analysis","volume":"33","author":"Freire","year":"2019","journal-title":"European Academy of Dermatology and Veneorology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Experimental Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"e14916","DOI":"10.1111\/dth.14916","article-title":"Treatments for alopecia areata: A systematic review and network meta-analysis","volume":"34","author":"Fukumoto","year":"2021","journal-title":"Dermatologic Therapy"},{"issue":"16","key":"10.1002\/14651858.CD013719.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0148|cit148","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2020 (developed by Evidence Prime, Inc.). Available from gradepro.org. McMaster University 2020"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40257-016-0230-4","article-title":"Treating alopecia areata: current practices versus new directions","volume":"18","author":"Gupta","year":"2017","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000501940","article-title":"Monotherapy for alopecia areata: a systematic review and network meta-analysis","volume":"5","author":"Gupta","year":"2019","journal-title":"Skin Appendage Disorders"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1590\/abd1806-4841.20142869","article-title":"Efficacy and safety of methotrexate in alopecia areata","volume":"89","author":"Hammerschmidt","year":"2014","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0152|cit152","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0153|cit153","unstructured":"Higgins JPT Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0154|cit154","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0155|cit155","unstructured":"Higgins JPT Li T Chapter 6: Choosing effect measures and computing estimates of effect In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2021. Available from www.training.cochrane.org\/handbook."},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaad.2018.04.018","article-title":"Topical Janus kinase inhibitors: a review of applications in dermatology","volume":"79","author":"Hosking","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7522","key":"10.1002\/14651858.CD013719.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0158|cit158","first-page":"1","article-title":"Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis","volume":"26","author":"Husein-ElAhmed","year":"2021","journal-title":"Journal of Dermatologic Treatment"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmunity Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2017.03.015","article-title":"Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata","volume":"77","author":"Jang","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013719.pub2-BIB0161|cit161","first-page":"e404","article-title":"Alopecia areata. Current situation and perspectives","volume":"115","author":"Juarez-Rendon","year":"2017","journal-title":"Archivos Argentinos de Pediatri\u0301a"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1346-8138.13613","article-title":"Efficacy and safety of superficial cryotherapy for alopecia areata: a retrospective, comprehensive review of 353 cases over 22 years","volume":"44","author":"Jun","year":"2017","journal-title":"Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjd.12863","article-title":"How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A critically appraised topic","volume":"170","author":"Kassim","year":"2014","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaad.2017.09.011","article-title":"Alopecia areata is a medical disease","volume":"78","author":"Korta","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD013719.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2174\/1874467210666170113104503","article-title":"Tofacitinib, an oral janus kinase inhibitor: perspectives in dermatology","volume":"24","author":"Kostovic","year":"2017","journal-title":"Current Medicinal Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000092287","article-title":"A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology: International Journal for Clinical and Investigative Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD013719.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/1346-8138.13933","article-title":"Management of alopecia areata: updates and algorithmic approach","volume":"44","author":"Lee","year":"2017","journal-title":"Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaad.2018.07.013","article-title":"Comorbidities in alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Lee","year":"2019","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.jisp.2017.10.003","article-title":"Tofacitinib for the treatment of severe alopecia areata in adults and adolescents","volume":"19","author":"Liu","year":"2018","journal-title":"Journal of Investigative Dermatology Symposium Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/bjd.15099","article-title":"Establishing and prioritizing research questions for the treatment of alopecia areata: the Alopecia Areata Priority Setting Partnership","volume":"176","author":"Macbeth","year":"2017","journal-title":"British Journal of Dermatology"},{"issue":"6419","key":"10.1002\/14651858.CD013719.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.288.6419.794-a","article-title":"Topical minoxidil in the treatment of alopecia areata","volume":"288","author":"Maitland","year":"1984","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0173|cit173","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"2-3","key":"10.1002\/14651858.CD013719.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013719.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaad.2017.09.054","article-title":"Treatment for facial alopecia areata: a systematic review with evidence-based analysis","volume":"78","author":"Murad","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines--part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaad.2017.10.048","article-title":"Objective outcome measures: collecting meaningful data on alopecia areata","volume":"79","author":"Olsen","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0179|cit179","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan - a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"Journal of Investigative Dermatology Symposium Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40272-017-0239-z","article-title":"Alopecia areata: an update on treatment options for children","volume":"19","author":"Peloquin","year":"2017","journal-title":"Paediatric Drugs"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000369406","article-title":"Alopecia areata","volume":"47","author":"Perera","year":"2015","journal-title":"Current Problems in Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0186|cit186","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2019"},{"issue":"5","key":"10.1002\/14651858.CD013719.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archderm.1992.01680150136027","article-title":"Prevalence of alopecia areata in the first national health and nutrition examination survey","volume":"128","author":"Safavi","year":"1992","journal-title":"Archives of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD013719.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrd.2017.267","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"17","author":"Schwartz","year":"2017","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0191|cit191","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013 gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"e2017047","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"Shim","year":"2017","journal-title":"Epidemiology and Health"},{"issue":"9","key":"10.1002\/14651858.CD013719.pub2-BIB0193|cit193","first-page":"751","article-title":"Alopecia areata: part 1: pathogenesis, diagnosis, and prognosis","volume":"61","author":"Spano","year":"2015","journal-title":"Canadian Family Physician"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0194|cit194","unstructured":"Stata StataCorp 2017"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: an appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/DER.0000000000000094","article-title":"Treatment of alopecia areata with topical sensitizers","volume":"26","author":"Sutherland","year":"2015","journal-title":"Dermatitis"},{"issue":"3","key":"10.1002\/14651858.CD013719.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0201|cit201","first-page":"397","article-title":"Epidemiology and burden of alopecia areata: a systematic review","volume":"8","author":"Villasante Fricke","year":"2015","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013719.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14764170600607368","article-title":"Use of the pulsed infrared diode laser (904 nm) in the treatment of alopecia areata","volume":"8","author":"Waiz","year":"2006","journal-title":"Journal of Cosmetic and Laser Therapy"},{"issue":"12","key":"10.1002\/14651858.CD013719.pub2-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.3390\/cells10123397","article-title":"The role of serum Th1, Th2, and Th17 cytokines in patients with alopecia areata: clinical implications","volume":"10","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1002\/14651858.CD013719.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1440-0960.2003.00654.x","article-title":"PUVA treatment of alopecia areata totalis and universalis: a retrospective study","volume":"44","author":"Whitmont","year":"2003","journal-title":"Australasian Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD013719.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00403-018-1843-7","article-title":"Expression and localization of VEGFR-2 in hair follicles during induced hair growth in mice","volume":"310","author":"Wu","year":"2018","journal-title":"Archives of Dermatological Research"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaad.2019.11.066","article-title":"Efficacy of different concentrations of intralesional triamcinolone acetonide for alopecia areata: a systematic review and meta-analysis","volume":"82","author":"Yee","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0207|cit207","doi-asserted-by":"crossref","unstructured":"Yoo KH Kim MN Kim BJ Kim CW Treatment of alopecia areata with fractional photothermolysis laser International Journal of Dermatology 2010 49 7 845 7 19627384","DOI":"10.1111\/j.1365-4632.2009.04230.x"},{"issue":"7","key":"10.1002\/14651858.CD013719.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2016.02.021","article-title":"Modified immunotherapy for alopecia areata","volume":"15","author":"Yoshimasu","year":"2016","journal-title":"Autoimmunity Reviews"},{"key":"10.1002\/14651858.CD013719.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"621","DOI":"10.25259\/IJDVL_975_19","article-title":"Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: a systematic review and meta-analysis","volume":"87","author":"Kim","year":"2021","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"issue":"9","key":"10.1002\/14651858.CD013719.pub2-BIB0210|cit210","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013719","article-title":"Treatments for alopecia areata: a network meta-analysis","author":"Novoa-Candia","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:33:07Z","timestamp":1778851987000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013719.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":210,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013719.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}